Histology and Neurobiology Unit (UHNeurob)

NEUROSCIENCES AND MENTAL HEALTH
OBJECTIUS

The Research Group of the Histology and Neurobiology Unit, UHNeurob, has developed basic research in the field of Cellular Neurobiology for more than three decades. It aims to study the molecular mechanisms that regulate neurotransmission and synaptic connectivity. Of particular interest is the study of the intracellular signaling triggered by neurotrophic, muscarinic, purinergic and cannabinoid receptors and which converges in kinases to regulate neurotransmission. The synapse under study is the neuromuscular junction during development, maturity, aging and in pathologies such as amyotrophic lateral sclerosis (ALS) or spinal muscular atrophy (SMA). In addition, we study the impact of physical exercise and experimental pharmacological treatments as therapies to preserve and strengthen synapses and the neuromuscular system.

RESPONSABLES
  • Dra. María Angel Lanuza

  • Presentation
  • Research lines
  • Book chapters
  • Group members
  • Projects
  • Transfer
  • Publications
  • Contact

The UHNeurob Group focuses its research on Cellular Neurobiology, in particular on the study of the basic mechanisms of activity-dependent synaptic regulation. Of particular interest is the study of the intracellular signaling that neurotrophic, muscarinic and purinergic and cannabinoid receptors trigger and that converges in kinases to regulate neurotransmission. The synapse under study is the neuromuscular junction.

With this idea, the group develops different lines of research with a common goal which is the knowledge of the mechanisms that regulate synaptic connectivity during development, maturity, aging and disease.

During development we study the mechanisms that direct the synaptic competition between neurons to innervate the same target cell. The consequence of this competition is the establishment of the adult pattern of stable but plastic synaptic connections, essential for learning and memory.

In the adult stage, the group is focused on the study of activity-dependent signaling pathways that regulate neurotransmission. The results in this area make it possible to understand the role of these pathways in the functioning of synapses and to determine which molecules could play a relevant role in pathologies that alter their normal functioning.

The UHNeurob group is also very interested in the study of the cellular and molecular mechanisms of neuromuscular diseases, particularly amyotrophic lateral sclerosis (ALS) and the impact of physical exercise as a therapy to preserve neuromuscular function. He also researches cellular and molecular changes in the neuromuscular system during aging. The final objective is, in both cases, the identification of therapeutic targets that prevent the disconnection and degeneration of the neuromuscular synapse to delay or prevent the neuronal degeneration that takes place in both cases. This research is of great interest to society since the preservation of the neuromuscular junction would improve the motor activities of the affected people.

At a technical level, methodological approaches are used in the field of microscopy, biochemistry and cellular and molecular biology, omics technologies and the evaluation of motor capacity. Rat and mouse animal models are used, some of them transgenic, and physical exercise and ex-vivo electrical stimulation techniques are applied to increase neuromuscular synaptic activity.

  • Cell neurobiology, synaptogenesis, mechanisms of regulation of synaptic activity and mechanisms of adaptation, remodeling and plasticity in the nervous system.
  • Intracellular signaling of neurotrophic, muscarinic, purinergic and cannabinoid receptors and associated kinases.
  • Retrograde regulation of neurotrophic signaling to maintain neuromuscular synapse homeostasis.
  • Molecular mechanisms that intervene and regulate synaptic transmission.
  • Regulatory mechanisms of synaptic connectivity during development, maturity, aging and disease. Configuration of neural circuits.
  • Cellular and molecular changes in the neuromuscular system during aging.
  • Cellular and molecular bases of neuromuscular diseases, in particular, amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).
  • Physical exercise as a regulatory therapy for the preservation and strengthening of the neuromuscular synapse in physiological and pathological conditions.

  • Tomàs JM, Garcia N, Lanuza MA, Nadal L, Tomàs M, Hurtado E, Simó A, Cilleros V. “Membrane receptor-induced changes of the protein kinases A and C activity may play a leading role in promoting developmental synapse elimination at the neuromuscular junction”. In: Synaptic Assembly and Neural Circuit Development. Ko, J., Zhang, C., eds (2018). Lausanne: Frontiers Media. ISSN 1664-8714, ISBN 978-2-88945-630-7, doi: 10.3389/978-2-88945-630-7. pp 124-132.

  • Tomàs JM, Garcia N, Lanuza MA, Santafé MM, Tomàs M, Nadal L, Hurtado E, Simó A, Cilleros V. “Presynaptic Membrane Receptors Modulate ACh Release, Axonal Competition and Synapse Elimination during Neuromuscular Junction Development” In: Synaptic Assembly and Neural Circuit Development. Ko, J., Zhang, C., eds (2018). Lausanne: Frontiers Media. ISSN 1664-8714, ISBN 978-2-88945-630-7, doi: 10.3389/978-2-88945-630-7. pp 157-168.

  • Activity-dependent retrograde regulation of the neurotrophic signaling pathways to maintain homeostasis of the neuromuscular synapse. Role in Amyotrophic Lateral Sclerosis

    PID2022-141252NB-I00
    Funding entity: Ministerio de Ciencia e Innovación.
    Duration: 31/08/2023 – 30/08/2026.
    Principal investigator: Lanuza Escolano, Maria Angel

  • 2021 SGR 01214 Suport a grups de recerca (SGR) URV – Grup de recerca consolidat

    Funding entity: Agència de Gestió d’Ajuts Universitaris i de Recerca.
    Duration: 2023 – 2025
    Principal investigator: Lanuza Escolano, Maria Angel

  • Effect of neuromuscular activity on muscarinic and neurotrophic synaptic signaling. Implication in Amyotrophic Lateral Sclerosis

    PID2019-106332GB-I00
    Funding entity: Ministerio de Ciencia, Innovación y Universidades.
    Duration: 31/05/2020 – 30/05/2024.
    Principal investigator: Lanuza Escolano, Maria Angel / Tomàs Ferré, Josep

  • Muscle activity and retrograde control of neurotransmission: effect of BDNF/TrkB/PKC signaling on synaptic vesicle proteins

    SAF2015-67143-P
    Funding entity: Ministerio de Economía y Competitividad.
    Duration: 01/01/2016 – 31/12/2018.
    Principal investigator: Tomàs Ferré, Josep / Lanuza Escolano, Maria Angel

  • Effect of neuromuscular activity on muscarinic and neurotrophic synaptic signaling. Implication in Amyotrophic Lateral Sclerosis

    PRE2020-092084
    Funding entity: Ministerio de Ciencia e Innovación.
    Duration: 31/08/2021 – 30/08/2025.
    Principal investigator: Lanuza Escolano, María Angel

  • Effect of neuromuscular activity on muscarinic and neurotrophic synaptic signaling in aging

    2023 FI_3 00176.
    Funding entity: Agència de Gestió d’Ajuts Universitaris i de Recerca.
    Duration: 30/04/2021 – 29/04/2025.
    Principal investigator: Lanuza Escolano, Maria Angel.

  • 2017 SGR 00704 Suport a grups de recerca (SGR) URV – Grup de recerca consolidat

    Funding entity: Agència de Gestió d’Ajuts Universitaris i de Recerca.
    Duration: 2017 – 2022
    Principal investigator: Tomàs Ferré, Josep

  • Formación e implicación en las actividades técnicas de laboratorio de la Unidad docente e investigadora de Histología y Neurobiología de la Facultad de Medicina y Ciencias de la Salud de la Universitat Rovira i Virgili

    PEJ2018-002805-A-MINECO.
    Funding entity: Ministerio de Ciencia, Innovación y Universidades / Universitat Rovira i Virgili.
    Duration: 31/08/2019 – 30/08/2022.
    Investigador Principal: Tomás Ferré, Josep

  • Neurotrophic factors and receptors assessment in P10 SMA mice under BIO101 treatment

    T22364S.
    Contract Company: Biophytis, SA (París, France)
    Duration: 17/10/2022 – 15/02/2024
    Principal investigator: Lanuza Escolano, Maria Angel.

  • Els antioxidants derivats de les llavors del raïm com molècules preventives en l’envelliment del sistema neuromuscular

    2022PRD-DIPTA-URV20
    Contract Company: Diputació de Tarragona
    Duration: 01/01/2022 – 31/12/2023.
    Investigador Principal: Garcia Sancho, Neus / Lanuza Escolano, Maria Angel

    Año

    Activity-dependent muscarinic signalling regulates presynaptic PKC pathway and neurotransmission machinery at the neuromuscular junction

    Polishchuk, A, Just-Borràs, L, Cilleros-Mañé, V, Balanyà-Segura, M, Simón, CS, Tomàs, M, El Hirchi, MJ, Díaz-Wallach, M, Hurtado, E, Tomàs, J, Lanuza, MA. 14/10/2025

    HDAC11 deficiency regulates age-related muscle decline and sarcopenia.

    Odria R, Cardús A, Gomis-Coloma C, Balanyà-Segura M, Mercado-Amarilla A, Maestre-Mora P, Poveda-Sabuco A, Domingo JC, Nogales-Gadea G, Gomez-Sanchez JA, Hurtado E, Suelves M. 01/08/2025

    Protective effects of grape seed procyanidin extract on neurotrophic and muscarinic signaling pathways in the aging neuromuscular junction.

    Balanyà-Segura M, Polishchuk A, Just-Borràs L, Cilleros-Mañé V, Silvera C, Jami-ElHirchi M, Pinent M, Ardévol A, Tomàs M, Lanuza MA, Hurtado E, Tomàs J. 06/05/2025

    Molecular Adaptations of BDNF/NT-4 Neurotrophic and Muscarinic Pathways in Ageing Neuromuscular Synapses

    Balanyà-Segura, M, Polishchuk, A, Just-Borràs, L, Cilleros-Mañé, V, Silvera, C, Ardévol, A, Tomàs, M, Lanuza, MA, Hurtado, E, Tomàs, J. 01/08/2024

    BDNF/TrkB signalling, in cooperation with muscarinic signalling, retrogradely regulates PKA pathway to phosphorylate SNAP-25 and Synapsin-1 at the neuromuscular junction

    Polishchuk, A, Cilleros-Mañé, V, Balanyà-Segura, M, Just-Borràs, L, Forniés-Mariné, A, Silvera-Simón, C, Tomàs, M, El Hirchi, MJ, Hurtado, E, Tomàs, J, Lanuza, MA. 23/07/2024

Membres De L’equip